首页|不改变宫腔形态的子宫肌瘤对反复种植失败患者助孕结局的影响研究

不改变宫腔形态的子宫肌瘤对反复种植失败患者助孕结局的影响研究

扫码查看
目的 探讨合并不改变宫腔形态的子宫肌瘤是否对反复种植失败(recurrent implantation failure,RIF)患者冻融胚胎移植(frozen-thawed embryo transfer,FET)周期的助孕结局产生不利影响.方法 采用双向队列研究,分析2018年1月1日至2023年12月31日期间就诊于北京大学第三医院妇产科生殖医学中心诊断为RIF患者的首次FET周期的资料,根据是否合并不改变宫腔形态的肌壁间肌瘤[2011年国际妇产联盟(International Federation of Gynecology and Obstetrics,FIGO)分型的3~6型],分为病例组(肌瘤患者,n=457)和对照组(非肌瘤患者,n=1 693),同时,通过SPSS27.0对两组的年龄、内膜厚度、周期类型、移植胚胎发育天数进行1∶2倾向性评分匹配,设定卡钳值为0.1,匹配后对照组共857例,比较匹配前后两组的临床妊娠率、人绒毛膜促性腺激素(human chorionic gonadotropin,hCG)阳性率、早期流产率等助孕结局.此后,在病例组患者中根据肌瘤的个数、大小、位置等特征进行亚组分析,研究肌瘤特征对FET助孕结局的影响.结果 在RIF患者FET周期中,病例组患者与匹配后对照组患者的临床妊娠率、早期流产率、hCG 阳性率差异均无统计学意义(均P>0.05);在肌瘤患者中,子宫肌瘤的最大直径为≥2 cm,<4 cm与较低的临床妊娠率(OR=0.441,95%CI:0.218~0.891,调整OR=0.408,P=0.022)及hCG阳性率(OR=0.374,95%CI:0.185~0.757,调整OR=0.337,P=0.006)有关.结论 FIGO分型的3~6型肌壁间肌瘤不影响RIF患者的解冻移植结局,同时,肌瘤的个数和位置也对助孕结局无影响;但是,相对于其他大小的肌壁间肌瘤而言,直径在2~4 cm间的肌瘤可能对胚胎着床存在潜在不利影响.
Impact of uterine fibroids that do not alter uterine cavity morphology on the pregnancy outcome of patients with recurrent implantation failure
Objective To investigate whether intramural fibroids that do not distort the uterine cavity adversely affect the reproductive outcomes of frozen-thawed embryo transfer(FET)cycles in patients with recurrent implantation failure(RIF).Methods A ambispective cohort study analyzed data from patients diagnosed with RIF undergoing their first FET cycle at Reproductive Medicine Center,Obstetrics and Gynecology,Peking University Third Hospital,from January 1,2018 to December 12,2023.Patients were categorized into case group(fibroid patients,n=457)and control group(non-fibroid patients,n=1 693)based on whether they had intramural fibroids that did not distort the uterine cavity[type 3-6 according to 2011 International Federation of Obstetrics and Gynecology(FIGO)classification].Propensity score matching was performed(1∶2 ratio)using SPSS27.0 to adjust for age,endometrial thickness,cycle type,and embryo type.After matching,there were 857 cases in control group.Pregnancy outcomes including clinical pregnancy rate,human chorionic gonadotropin(hCG)positive rate,and early miscarriage rate were compared between the two groups.Subgroup analyses were conducted in the case group based on characteristics such as number,size,and location of the fibroids to study their impact on the outcomes of FET cycles.Results In patients with RIF undergoing FET cycles,there were no statistically significant differences between case group and the matched control group in terms of clinical pregnancy rate,early miscarriage rate,and hCG positive rate(all P>0.05).Within the fibroid patients,however,fibroids with a maximum diameter≥2 cm and<4 cm were associated with lower clinical pregnancy rate(OR=0.441,95%CI:0.218-0.891,a OR=0.408,P=0.022)and lower hCG positive rate(OR=0.374,95%CI:0.185-0.757,a OR=0.337,P=0.006)compared with the other sizes of intramural fibroids.Conclusion Type 3-6 intramural fibroids according to the FIGO classification do not affect the outcomes of FET cycles in patients with RIF.Additionally,the number and location of fibroids also do not affect reproductive outcomes.However,intramural fibroids with a diameter between 2-4 cm may potentially have adverse effects on embryo implantation compared with other sizes of intramural fibroids.

Pregnancy outcomeUterine fibroidsRecurrent implantation failure

杨子萱、王洋、陈立雪、杨硕、李蓉

展开 >

北京大学第三医院妇产科生殖医学中心,北京 100191

妊娠结局 子宫肌瘤 反复种植失败

2024

中华生殖与避孕杂志
上海计划生育科学研究所

中华生殖与避孕杂志

CSTPCD北大核心
影响因子:0.989
ISSN:2096-2916
年,卷(期):2024.44(12)